Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
15:10 | Intuitive Surgical Stock Gains 12.7% QTD: Is it Still a Buy Now? | ||
15:10 | Should You Buy, Sell or Hold Oracle Stock Before Q4 Earnings? | ||
15:10 | Can Shrink Gains Continue to Support Target's Margins? | ||
14:34 | Musk-Trump Messy Breakup Wipes Out $150B in TSLA Stock: What's Next? | ||
14:34 | Here's Why You Must Add National Grid Stock to Your Portfolio Now | ||
14:34 | APLD Accelerates Hyperscale Growth With $5B Expansion Backing | ||
14:34 | BMY Collaborates for Oncology Drug: Will This Boost Its Portfolio? | ||
14:34 | Transocean Strengthens Backlog With Equinor's Contract Extension | ||
14:34 | MKL Outperforms Industry, Trades at a Discount: How to Play the Stock? | ||
14:34 | Can New Cancer Drug Emrelis Drive AbbVie's Oncology Franchise? | ||
14:34 | Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape? | ||
14:34 | StoneCo's Q1 Repricing Drives Gross Profit Surge Amid Rate Pressures | ||
14:34 | Can New Executive Orders Boost Constellation Energy's Nuclear Growth? | ||
14:34 | Equinor, Centrica Strike 10-Year UK Gas Supply Agreement | ||
14:34 | ExxonMobil, SOCAR Sign Deal to Explore Onshore Oil in Azerbaijan | ||
14:34 | Is it Apt to Retain Omnicell Stock in Your Portfolio Now? | ||
14:34 | Micron vs. Lam Research: Which Semiconductor Stock Is a Better Buy? | ||
14:10 | Crown Castle Stock Up 10.5% Year to Date: Will the Trend Continue? | ||
14:10 | Will VZ's Growing Prowess in V2X Technology Boost Competitive Edge? | ||
14:10 | Is it Wise to Retain Lamar Advertising Stock in Your Portfolio Now? | ||
14:10 | Is Innovation the Secret Sauce in Nomad Foods' Margin Playbook? | ||
14:10 | Southern's Subsidiary Backs Edged to Expand Green Data Centers | ||
14:10 | The Trade Desk Tanks 47% in Six Months: Should You Avoid TTD Stock? | ||
14:10 | Insiders Are Buying Prairie Operating Co. - Should You Too? | ||
14:10 | ZIM Moves Ahead on Dividend Strength: A Sign of More Smooth Sailing? |